You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

ATM mutation

Showing 1 - 25 of 2,670
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metastatic Solid Tumor, BRCA1 Mutation, BRCA2 Mutation Trial in San Francisco (Niraparib, Irinotecan)

Not yet recruiting
  • Metastatic Solid Tumor
  • +4 more
  • San Francisco, California
    University of California, San Francisco
Jan 12, 2023

ATM Gene Mutation, BRCA1 Gene Mutation, BRCA2 Gene Mutation Trial in Sacramento (Niraparib, Niraparib Tosylate Monohydrate,

Recruiting
  • ATM Gene Mutation
  • +16 more
  • Sacramento, California
    University of California Davis Comprehensive Cancer Center
Oct 27, 2022

ARID1A Gene Mutation, ATM Gene Mutation, ATR Gene Mutation Trial in United States (Olaparib)

Recruiting
  • ARID1A Gene Mutation
  • +15 more
  • Scottsdale, Arizona
  • +4 more
Dec 13, 2022

An Intervention to Increase Genetic Testing in Families Who May

Recruiting
  • BRCA1 Mutation
  • +21 more
  • Intervention Arm At-risk Relative/ARR Contacts
  • +5 more
  • Basking Ridge, New Jersey
  • +7 more
Nov 22, 2022

Ataxia Telangiectasia, ATM Gene Mutation Trial in Nijmegen (Vitamin B3)

Completed
  • Ataxia Telangiectasia
  • ATM Gene Mutation
  • Vitamin B3
  • Nijmegen, Netherlands
    Radboudumc
Jul 21, 2022

Prostatic Tumor, Prostate Cancer, BRCA2 Mutation Trial in Boston (Prostate cancer screening)

Recruiting
  • Prostatic Neoplasm
  • +7 more
  • Prostate cancer screening
  • Boston, Massachusetts
    Massachusetts General Hospital
Nov 30, 2021

Advanced Malignant Tumor, ATM Gene Mutation, BRCA1 Gene Mutation Trial in Houston (Laboratory Biomarker Analysis,

Active, not recruiting
  • Advanced Malignant Neoplasm
  • +7 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Feb 21, 2022

Advanced Solid Tumors Trial in Worldwide (Elimusertib (BAY1895344), Pembrolizumab)

Active, not recruiting
  • Advanced Solid Tumors
  • Palo Alto, California
  • +15 more
Jan 6, 2023

Advanced Breast Cancer, HER2/Neu Negative, Triple-Negative Breast Cancer Trial in Stanford (Talazoparib Tosylate)

Active, not recruiting
  • Advanced Breast Cancer
  • +2 more
  • Talazoparib Tosylate
  • Stanford, California
    Stanford University Hospitals and Clinics
Nov 16, 2022

Melanoma Trial (Fluzoparib Camrelizumab Temozolomide)

Not yet recruiting
  • Melanoma
  • Fluzoparib Camrelizumab Temozolomide
  • (no location specified)
Aug 9, 2023

Metastatic Castration Resistant Prostate Cancer Trial in Worldwide (Rucaparib)

Completed
Has Results
  • Metastatic Castration Resistant Prostate Cancer
  • Birmingham, Alabama
  • +148 more
Jun 14, 2022

Her-2 Negative Breast Cancer, HRR Gene Mutation Trial in Guangzhou (Camrelizumab, Fluzoparib, Nab-paclitaxel)

Recruiting
  • Her-2 Negative Breast Cancer
  • HRR Gene Mutation
  • Guangzhou, Guangdong, China
    First Affiliated Hospital, Sun Yat-Sen University
Mar 7, 2023

Chronic Lymphocytic Leukemia Trial in Salt Lake City (RP-3500 in combination with Olaparib)

Recruiting
  • Chronic Lymphocytic Leukemia
  • RP-3500 in combination with Olaparib
  • Salt Lake City, Utah
    Huntsman Cancer Institute at the University of Utah
Sep 23, 2022

Renal Cell Carcinoma, Metastatic Renal Cell Carcinoma, Kidney Cancer Trial in Baltimore (Olaparib)

Recruiting
  • Renal Cell Carcinoma
  • +4 more
  • Baltimore, Maryland
    Johns Hopkins Sidney Kimmel Comprehensive Cancer Center
Mar 14, 2022

Blood and Bone Marrow Samples From Previously Untreated Chronic

Completed
  • Leukemia
  • fluorescence in situ hybridization
  • +6 more
  • San Diego, California
  • +34 more
Aug 2, 2022

Pilot Study of Pancreatic Cancer Screening

Recruiting
  • Pancreatic Carcinoma
  • Biospecimen Collection
  • +4 more
  • San Francisco, California
    University of California San Francisco
Apr 13, 2022

Advanced Malignant Solid Tumor, Ann Arbor Stage III Non-Hodgkin Lymphoma, Ann Arbor Stage IV Non-Hodgkin Lymphoma Trial in

Recruiting
  • Advanced Malignant Solid Neoplasm
  • +44 more
  • Biopsy
  • +23 more
  • Birmingham, Alabama
  • +166 more
Feb 2, 2023

Screening for Prostate Cancer, GIFTS Study

Enrolling by invitation
  • Metastatic Prostate Carcinoma
  • +2 more
  • Questionnaire
  • +4 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jul 22, 2022

Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma, PDAC Trial in Rochester (Bio-specimen Collection: Blood, Bio-specimen

Recruiting
  • Pancreatic Cancer
  • +3 more
  • Bio-specimen Collection: Blood
  • +2 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Nov 21, 2023

Prostate Cancer Trial (Multiparameric MRI with injection)

Not yet recruiting
  • Prostate Cancer
  • Multiparameric MRI with injection
  • (no location specified)
May 12, 2022

Frequency of Occult Breast Cancer After Prophylactic Mastectomy

Recruiting
  • Genetic Predisposition
  • +3 more
  • Histopathological confirmation
  • Karachi, Sindh, Pakistan
    Aga Khan University Hospital
Mar 15, 2023

Metastatic Melanoma Trial in San Francisco (Niraparib)

Recruiting
  • Metastatic Melanoma
  • San Francisco, California
    California Pacific Medical Center Research Institute
Oct 15, 2021

Prostate Cancer Screening Trial in Chicago (Prostate MRI)

Recruiting
  • Prostate Cancer Screening
  • Prostate MRI
  • Chicago, Illinois
    University of Chicago
Nov 2, 2022

Germline Mutations Associated With Hereditary Pancreatic Cancer

Recruiting
  • Pancreatic Cancer
  • Pancreatic Adenocarcinoma
  • Invitae Multi-Cancer Panel ®
  • Mexico City, Mexico
    Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubi
Mar 22, 2022

Pancreas Cancer, Peutz-Jeghers Syndrome (PJS), Gene Mutation Trial in United States (drug, diagnostic test, other)

Recruiting
  • Pancreas Cancer
  • +4 more
  • New Haven, Connecticut
  • +7 more
Dec 12, 2022